Related Experiment Videos
Discovering novel chemotherapeutic drugs for the third millennium
1CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, U.K.
Abstract:
There is enormous potential for the discovery of innovative cancer drugs with improved efficacy and selectivity for the third millennium. In this review we show how novel mechanism-based agents are being discovered by focusing on the molecular targets and pathways that are causally involved in cancer formation, maintenance and progression. We also show how new technologies, from genomics through high through-put bioscience, combinatorial chemistry, rational drug design and molecular pharmacodynamic and imaging techniques, are accelerating the pace of cancer drug discovery. The process of contemporary small molecule drug discovery is described and progress and current issues are reviewed. New and potential targets and pathways for therapeutic intervention are illustrated. The first examples of a new generation of molecular therapeutics are now entering hypothesis-testing clinical trials and showing activity. The early years of the new millennium will see a range of exciting new agents moving from bench to bedside and beginning to impact on the management and cure of cancer.
Insights
Innovative cancer drugs are being discovered by targeting molecular pathways and utilizing new technologies. This approach accelerates the development of novel therapeutics, offering hope for improved cancer treatment and management.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Cancer remains a major global health challenge, necessitating the development of more effective and selective treatments.
- Traditional cancer therapies often have limitations in efficacy and can cause significant side effects.
Purpose of the Study:
- To review the discovery of novel, mechanism-based cancer drugs.
- To highlight the role of molecular targets and pathways in cancer development.
- To showcase how new technologies are advancing cancer drug discovery.
Main Methods:
- Focusing on molecular targets and pathways causally involved in cancer.
- Leveraging genomics, high-throughput bioscience, and combinatorial chemistry.
- Employing rational drug design, molecular pharmacodynamics, and imaging techniques.
Main Results:
- Novel mechanism-based agents are being identified and developed.
- New technologies are significantly accelerating the drug discovery process.
- Early-stage molecular therapeutics are entering clinical trials with promising activity.
Conclusions:
- The third millennium holds immense potential for innovative cancer drug discovery.
- A new generation of molecular therapeutics is emerging, moving from research to clinical application.
- These advancements are poised to significantly impact cancer management and cure.
Related Concept Videos
01:26Drug Discovery: Overview
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:29Pharmacogenomics: Identification of New Drug Targets